Listed since 1987
The VBG Group’s Series B share is traded on Nasdaq Stockholm Mid Cap under the ticker VBG B. The Series A shares, which represent 52 per cent of the votes in the VBG Group, are held by three foundations: the Herman Krefting Foundation for Allergy and Asthma Research, the SLK Employees’ Foundation and the VBG-SLK Foundation.
Dividend and dividend policy
According to its dividend policy, in normal circumstances the VBG Group will distribute 30.0% of the Group’s net earnings. Over the last five years, an average 32.4% of net profit has been distributed. It should be noted that no dividend was distributed from earnings in 2019 as a consequence of the uncertainty around the ongoing pandemic, which negatively impacted the average proportion of the dividend. If 2019 is excluded from the calculation of the proportion of the dividend, this totals 40.5% of net profit.
In March 2012, the Board of Directors adopted a policy stipulating 30 per cent as the level of the dividend the shareholders can expect under normal circumstances.
Per share data
|Share price, SEK||140.00||188.00||154.50||157.50||126.80|
|Cash flow from operating activities, SEK||12.38||1.48||17.85||17.55||10.14|
|Dividend yield, %||3.93||2.66||2.91||3.17||3.55|
|Total number of outstanding shares (thousands)||25,004||25,004||25,004||25,004||25,004|
|Average number of outstanding shares (thousands)||25,004||25,004||25,004||25,004||25,004|
*Proposed dividend per share.
**Proposed dividend for 2019 earnings, SEK 5.00, withdrawn at the 2020 Annual General Meeting.